About Oculis
Oculis is a company based in Barcelona (Spain) founded in 2006. It operates as a Professional Services. Oculis has raised $20.52 million across 1 funding round from investors including Bay City Capital, Novartis Venture Fund and Brunnur Ventures. Oculis offers products and services including Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology. Oculis operates in a competitive market with competitors including Clínica Baviera, Centro de Oftalmologia Barraquer, Optica Torres, Vistalser Oftalmologa Todos los derechos reservados and Deutsche Augen Klinik, among others.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20.52 M (USD)
in 1 rounds
-
Latest Funding Round
$20.52 M (USD), Series B
Jan 04, 2018
-
Investors
Bay City Capital
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oculis
Oculis offers a comprehensive portfolio of products and services, including Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology.
Surgical treatment for cataracts is provided to patients.
Vision correction through refractive surgery is offered here.
Eye care for children is delivered by specialists.
Funding Insights of Oculis
Oculis has successfully raised a total of $20.52M through 1 strategic funding round. The most recent funding activity was a Series B round of $20.52 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oculis
Oculis has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Bay City Capital, Novartis Venture Fund and Brunnur Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Stage-agnostic investments in US life-sciences sectors are managed.
|
Locked | Locked | Locked | |
|
Investments are made in innovative life science companies globally.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward startups by the firm.
|
Locked | Locked | Locked |
Investor details for Oculis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oculis
Investment portfolio details for Oculis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oculis
Detailed financials for Oculis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oculis Comparisons
Peer comparison for Oculis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oculis
Oculis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clínica Baviera, Centro de Oftalmologia Barraquer, Optica Torres, Vistalser Oftalmologa Todos los derechos reservados and Deutsche Augen Klinik, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of eye care clinics
|
|
| Locked | Locked | Locked |
Chain of eye care clinics
|
|
| Locked | Locked | Locked |
Provides eye examinations, glasses, lenses, and audiology solutions in Spain.
|
|
| Locked | Locked | Locked |
Offers laser eye surgeries for vision correction and eye conditions.
|
|
| Locked | Locked | Locked |
Provides eye examinations, surgeries, and treatments for vision conditions in Spain.
|
Detailed competitors of Oculis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oculis
Complete news archive for Oculis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oculis
Oculis was founded in 2006 and raised its 1st funding round 12 years after it was founded.
Oculis is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Oculis is a funded company, having raised a total of $20.52M across 1 funding round to date.
Oculis is established as an ophthalmology institute based in Spain, specializing in a wide range of eye care services. Comprehensive treatments such as cataract surgery, refractive surgery, and pediatric ophthalmology are provided. Various eye conditions including glaucoma, retina issues, and strabismus are addressed. Emergency 24-hour ophthalmological care is also offered to patients. Diagnostic tests and visual therapy are included among the solutions delivered. The institute serves both individual patients and collaborates with medical centers and organizations in the healthcare sector.
Oculis's top competitors include Clínica Baviera, Centro de Oftalmologia Barraquer and Optica Torres.
Oculis offers Cataract Surgery, Refractive Surgery, and Pediatric Ophthalmology.
Oculis has 5 investors. Key investors include Bay City Capital, Novartis Venture Fund, Brunnur Ventures, Silfurberg, and Pivotal Life Sciences.